Menu
Your Cart

Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1

Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
$91.66
  • Stock: In Stock
  • Model: 178643

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Solution for inhalations Spiolto Respimat is shown as the supporting broncholitic therapy for relief of symptoms at adult patients with a chronic obstructive disease of easy (HOBL).

Structure

Active ingredients: tiotropiya, olodaterol;

1 inhalation contains 2.5 mkg a tiotropiya (in the form of monohydrate bromide), 2.5 mkg to an olodaterol (in the form of a hydrochloride);

Excipients: a benzalkoniya chloride, sodium edetat a dihydrate, water the purified, hydrochloric acid 1M.

Contraindication

Hypersensitivity to active ingredients or other components of medicine.

Hypersensitivity to atropine or its derivatives, for example to an ipratropiya or an oksitropiya in the anamnesis.

Route of administration Medicine is intended to

by

only for inhalation application. The cartridge can be used only with the RESPIMAT inhalation device.

Two breaths by means of an inhaler of RESPIMAT contain one dose.

Feature of application

Pregnant

Should avoid use of medicine.

by

Children

it is not applied.

Drivers

With care.

Overdose

High doses a tiotropiya can cause anticholinergic signs and symptoms.

Overdose olodateroly can lead

to 2 expressed the effects typical for β - adrenomimetik, for example, to ischemia of a myocardium, arterial hypertension or hypotension, tachycardia, arrhythmia, heartbeat, dizziness, nervousness, insomnia, concern, a headache, a tremor, dryness in a mouth, a muscular spasm, nausea, fatigue, to deterioration in health, a hypopotassemia, hyperglycemia and a metabolic acidosis.

Should stop use of the medicine Spiolto Respimat. The supporting and symptomatic therapy is shown.

Side effects

Serious side reactions of anticholinergic character include glaucoma, a lock, impassability of intestines, including paralytic impassability of intestines and an ischuria.

Interaction

Simultaneous application a bromide tiotropiya with other anticholinergics was not investigated by

and therefore it is not recommended.

Simultaneous use of other adrenergic medicines (independently or as a part of combination therapy) can enhance undesirable effects of the medicine Spiolto Respimat.

Storage conditions

to Store

at a temperature not above 25 °C. Not to freeze!

to Store

out of children's reach!

Expiration date - 3 years.

Specifications

Characteristics
Active ingredients Olodaterola hydrochloride, Tiotropiya bromide
Applicant Boehringer Ingelheim
Code of automatic telephone exchange R03AL06 Olodaterol and tiotropiya bromide
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Original
Origin Chemical
Prescription status According to the prescription
Primary packing cartridge
Producer BOEHRINGER INGELCHEIM PHARM GMBH AND TO
Quantity in packing 4 ml
Release form solution for inhalations
Route of administration For inhalation
Sign Import
Storage temperature from 5 °C to 30 °C
Trade name Spiolto